Nektar Therapeutics
NKTR
#5687
Rank
NZ$2.00 B
Marketcap
NZ$98.49
Share price
-1.37%
Change (1 day)
278.67%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$7.17

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$7.32. In 2024 the company made an earnings per share (EPS) of NZ-$6.06 an increase over its 2023 EPS that were of NZ-$37.91.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.1718.29%
2024NZ-$6.06-84.02%
2023NZ-$37.91-25.89%
2022NZ-$51.15-31.12%
2021NZ-$74.2614.86%
2020NZ-$64.65-1.19%
2019NZ-$65.43-163.96%
2018NZ$102.30-725.4%
2017NZ-$16.36-42.73%
2016NZ-$28.5683.33%
2015NZ-$15.5839.53%
2014NZ-$11.16-69.29%
2013NZ-$36.35-6.67%
2012NZ-$38.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$22.55-408.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98-140.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.14-279.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
NZ$0.01731-100.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.25-171.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
NZ-$1.14-84.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.58-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
NZ$18.07-346.79%๐Ÿ‡บ๐Ÿ‡ธ USA